Global and Japan Platinum-based Anticancer Drugs Market Insights, Forecast to 2027

Global and Japan Platinum-based Anticancer Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Platinum-based Anticancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Platinum-based Anticancer Drugs Market Size Growth Rate by Type
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Oxaliplatin
1.2.5 Nedaplatin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Platinum-based Anticancer Drugs Market Size Growth Rate by Application
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.3.5 Esophageal Cancer
1.3.6 NSCLC
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Platinum-based Anticancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Platinum-based Anticancer Drugs Revenue 2016-2027
2.1.2 Global Platinum-based Anticancer Drugs Sales 2016-2027
2.2 Global Platinum-based Anticancer Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Platinum-based Anticancer Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Platinum-based Anticancer Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Platinum-based Anticancer Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Platinum-based Anticancer Drugs Revenue Forecast by Region (2022-2027)
3 Global Platinum-based Anticancer Drugs Competitor Landscape by Players
3.1 Global Top Platinum-based Anticancer Drugs Manufacturers by Sales
3.1.1 Global Platinum-based Anticancer Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Platinum-based Anticancer Drugs Manufacturers by Revenue
3.2.1 Key Platinum-based Anticancer Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Platinum-based Anticancer Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Platinum-based Anticancer Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Platinum-based Anticancer Drugs Revenue in 2020
3.2.6 Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Platinum-based Anticancer Drugs Price by Manufacturers
3.4 Global Platinum-based Anticancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Platinum-based Anticancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Platinum-based Anticancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Platinum-based Anticancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Platinum-based Anticancer Drugs Market Size by Type (2016-2021)
4.1.1 Global Platinum-based Anticancer Drugs Sales by Type (2016-2021)
4.1.2 Global Platinum-based Anticancer Drugs Revenue by Type (2016-2021)
4.1.3 Platinum-based Anticancer Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Platinum-based Anticancer Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Platinum-based Anticancer Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Platinum-based Anticancer Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Platinum-based Anticancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Platinum-based Anticancer Drugs Market Size by Application (2016-2021)
5.1.1 Global Platinum-based Anticancer Drugs Sales by Application (2016-2021)
5.1.2 Global Platinum-based Anticancer Drugs Revenue by Application (2016-2021)
5.1.3 Platinum-based Anticancer Drugs Price by Application (2016-2021)
5.2 Platinum-based Anticancer Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Platinum-based Anticancer Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Platinum-based Anticancer Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Platinum-based Anticancer Drugs Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Platinum-based Anticancer Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Platinum-based Anticancer Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Platinum-based Anticancer Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Platinum-based Anticancer Drugs Market Share in Global Market 2016-2027
6.2 Japan Platinum-based Anticancer Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Platinum-based Anticancer Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Platinum-based Anticancer Drugs Players by Revenue (2016-2021)
6.3 Japan Platinum-based Anticancer Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Platinum-based Anticancer Drugs Price by Type (2016-2021)
6.4 Japan Platinum-based Anticancer Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Platinum-based Anticancer Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Platinum-based Anticancer Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Platinum-based Anticancer Drugs Price Forecast by Type (2022-2027)
6.5 Japan Platinum-based Anticancer Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Platinum-based Anticancer Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Platinum-based Anticancer Drugs Price by Application (2016-2021)
6.6 Japan Platinum-based Anticancer Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Platinum-based Anticancer Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Platinum-based Anticancer Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Platinum-based Anticancer Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Platinum-based Anticancer Drugs Market Size YoY Growth 2016-2027
7.2 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
7.2.1 North America Platinum-based Anticancer Drugs Sales by Country (2016-2021)
7.2.2 North America Platinum-based Anticancer Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Platinum-based Anticancer Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Platinum-based Anticancer Drugs Market Size YoY Growth 2016-2027
9.2 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
9.2.1 Europe Platinum-based Anticancer Drugs Sales by Country (2016-2021)
9.2.2 Europe Platinum-based Anticancer Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Platinum-based Anticancer Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
10.2.1 Latin America Platinum-based Anticancer Drugs Sales by Country (2016-2021)
10.2.2 Latin America Platinum-based Anticancer Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Platinum-based Anticancer Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Corporation Information
12.1.2 Sanofi-Aventis Description and Business Overview
12.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi-Aventis Platinum-based Anticancer Drugs Products Offered
12.1.5 Sanofi-Aventis Recent Development
12.2 Yakult honsha
12.2.1 Yakult honsha Corporation Information
12.2.2 Yakult honsha Description and Business Overview
12.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Yakult honsha Platinum-based Anticancer Drugs Products Offered
12.2.5 Yakult honsha Recent Development
12.3 Dr Reddy's laboratories
12.3.1 Dr Reddy's laboratories Corporation Information
12.3.2 Dr Reddy's laboratories Description and Business Overview
12.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Products Offered
12.3.5 Dr Reddy's laboratories Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Corporation Information
12.4.2 Sun Pharmaceutical Description and Business Overview
12.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Products Offered
12.4.5 Sun Pharmaceutical Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Description and Business Overview
12.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Platinum-based Anticancer Drugs Products Offered
12.5.5 Teva Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Corporation Information
12.6.2 Fresenius Kabi Description and Business Overview
12.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fresenius Kabi Platinum-based Anticancer Drugs Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 Hospira(Pfizer)
12.7.1 Hospira(Pfizer) Corporation Information
12.7.2 Hospira(Pfizer) Description and Business Overview
12.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Products Offered
12.7.5 Hospira(Pfizer) Recent Development
12.8 Mylan
12.8.1 Mylan Corporation Information
12.8.2 Mylan Description and Business Overview
12.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mylan Platinum-based Anticancer Drugs Products Offered
12.8.5 Mylan Recent Development
12.9 Taj Pharmaceuticals
12.9.1 Taj Pharmaceuticals Corporation Information
12.9.2 Taj Pharmaceuticals Description and Business Overview
12.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Products Offered
12.9.5 Taj Pharmaceuticals Recent Development
12.10 Jiangsu Hengrui Medicine
12.10.1 Jiangsu Hengrui Medicine Corporation Information
12.10.2 Jiangsu Hengrui Medicine Description and Business Overview
12.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Products Offered
12.10.5 Jiangsu Hengrui Medicine Recent Development
12.11 Sanofi-Aventis
12.11.1 Sanofi-Aventis Corporation Information
12.11.2 Sanofi-Aventis Description and Business Overview
12.11.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi-Aventis Platinum-based Anticancer Drugs Products Offered
12.11.5 Sanofi-Aventis Recent Development
12.12 Jiangsu Aosaikang Pharmaceutical
12.12.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
12.12.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
12.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Jiangsu Aosaikang Pharmaceutical Products Offered
12.12.5 Jiangsu Aosaikang Pharmaceutical Recent Development
12.13 Qilu Pharmaceutical
12.13.1 Qilu Pharmaceutical Corporation Information
12.13.2 Qilu Pharmaceutical Description and Business Overview
12.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Qilu Pharmaceutical Products Offered
12.13.5 Qilu Pharmaceutical Recent Development
12.14 Hisun Pharmaceutical
12.14.1 Hisun Pharmaceutical Corporation Information
12.14.2 Hisun Pharmaceutical Description and Business Overview
12.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Hisun Pharmaceutical Products Offered
12.14.5 Hisun Pharmaceutical Recent Development
12.15 Luoxin
12.15.1 Luoxin Corporation Information
12.15.2 Luoxin Description and Business Overview
12.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Luoxin Products Offered
12.15.5 Luoxin Recent Development
12.16 Lingnan Pharmacy
12.16.1 Lingnan Pharmacy Corporation Information
12.16.2 Lingnan Pharmacy Description and Business Overview
12.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Lingnan Pharmacy Products Offered
12.16.5 Lingnan Pharmacy Recent Development
12.17 Hansoh Pharma
12.17.1 Hansoh Pharma Corporation Information
12.17.2 Hansoh Pharma Description and Business Overview
12.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Hansoh Pharma Products Offered
12.17.5 Hansoh Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Platinum-based Anticancer Drugs Industry Trends
13.2 Platinum-based Anticancer Drugs Market Drivers
13.3 Platinum-based Anticancer Drugs Market Challenges
13.4 Platinum-based Anticancer Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Platinum-based Anticancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Cisplatin
Table 3. Major Manufacturers of Carboplatin
Table 4. Major Manufacturers of Oxaliplatin
Table 5. Major Manufacturers of Nedaplatin
Table 6. Major Manufacturers of Others
Table 7. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Platinum-based Anticancer Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Platinum-based Anticancer Drugs Sales by Regions (2016-2021) & (K Units)
Table 10. Global Platinum-based Anticancer Drugs Sales Market Share by Regions (2016-2021)
Table 11. Global Platinum-based Anticancer Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Platinum-based Anticancer Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Platinum-based Anticancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Platinum-based Anticancer Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Platinum-based Anticancer Drugs Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Platinum-based Anticancer Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 19. Platinum-based Anticancer Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 21. Global Platinum-based Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Platinum-based Anticancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum-based Anticancer Drugs as of 2020)
Table 23. Key Manufacturers Platinum-based Anticancer Drugs Price (2016-2021) (US$/Unit)
Table 24. Platinum-based Anticancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Platinum-based Anticancer Drugs Product Type
Table 26. Date of International Manufacturers Enter into Platinum-based Anticancer Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Platinum-based Anticancer Drugs Sales by Type (2016-2021) (K Units)
Table 29. Global Platinum-based Anticancer Drugs Sales Share by Type (2016-2021)
Table 30. Global Platinum-based Anticancer Drugs Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Platinum-based Anticancer Drugs Revenue Share by Type (2016-2021)
Table 32. Platinum-based Anticancer Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 33. Global Platinum-based Anticancer Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Platinum-based Anticancer Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Platinum-based Anticancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 38. Global Platinum-based Anticancer Drugs Sales by Application (2016-2021) (K Units)
Table 39. Global Platinum-based Anticancer Drugs Sales Share by Application (2016-2021)
Table 40. Global Platinum-based Anticancer Drugs Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Platinum-based Anticancer Drugs Revenue Share by Application (2016-2021)
Table 42. Platinum-based Anticancer Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 43. Global Platinum-based Anticancer Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Platinum-based Anticancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Platinum-based Anticancer Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 48. Japan Platinum-based Anticancer Drugs Sales (K Units) of Key Companies (2016-2021)
Table 49. Japan Platinum-based Anticancer Drugs Sales Share by Company (2016-2021)
Table 50. Japan Platinum-based Anticancer Drugs Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Platinum-based Anticancer Drugs Revenue Share by Company (2016-2021)
Table 52. Japan Platinum-based Anticancer Drugs Sales (K Units) by Type (2016-2021)
Table 53. Japan Platinum-based Anticancer Drugs Sales Share by Type (2016-2021)
Table 54. Japan Platinum-based Anticancer Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Platinum-based Anticancer Drugs Price (US$/Unit) by Type (2016-2021)
Table 56. Japan Platinum-based Anticancer Drugs Sales (K Units) by Type (2022-2027)
Table 57. Japan Platinum-based Anticancer Drugs Sales Share by Type (2022-2027)
Table 58. Japan Platinum-based Anticancer Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Platinum-based Anticancer Drugs Revenue Share by Type (2022-2027)
Table 60. Japan Platinum-based Anticancer Drugs Price (US$/Unit) by Type (2022-2027)
Table 61. Japan Platinum-based Anticancer Drugs Sales (K Units) by Application (2016-2021)
Table 62. Japan Platinum-based Anticancer Drugs Sales Share by Application (2016-2021)
Table 63. Japan Platinum-based Anticancer Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Platinum-based Anticancer Drugs Price (US$/Unit) by Application (2016-2021)
Table 65. Japan Platinum-based Anticancer Drugs Sales (K Units) by Application (2022-2027)
Table 66. Japan Platinum-based Anticancer Drugs Sales Share by Application (2022-2027)
Table 67. Japan Platinum-based Anticancer Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Platinum-based Anticancer Drugs Revenue Share by Application (2022-2027)
Table 69. Japan Platinum-based Anticancer Drugs Price (US$/Unit) by Application (2022-2027)
Table 70. North America Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 71. North America Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 72. North America Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Region (2016-2021)
Table 78. Europe Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 79. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 80. Europe Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 82. Latin America Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 90. Sanofi-Aventis Corporation Information
Table 91. Sanofi-Aventis Description and Business Overview
Table 92. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 93. Sanofi-Aventis Platinum-based Anticancer Drugs Product
Table 94. Sanofi-Aventis Recent Development
Table 95. Yakult honsha Corporation Information
Table 96. Yakult honsha Description and Business Overview
Table 97. Yakult honsha Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 98. Yakult honsha Product
Table 99. Yakult honsha Recent Development
Table 100. Dr Reddy's laboratories Corporation Information
Table 101. Dr Reddy's laboratories Description and Business Overview
Table 102. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 103. Dr Reddy's laboratories Product
Table 104. Dr Reddy's laboratories Recent Development
Table 105. Sun Pharmaceutical Corporation Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Sun Pharmaceutical Product
Table 109. Sun Pharmaceutical Recent Development
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Teva Product
Table 114. Teva Recent Development
Table 115. Fresenius Kabi Corporation Information
Table 116. Fresenius Kabi Description and Business Overview
Table 117. Fresenius Kabi Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Fresenius Kabi Product
Table 119. Fresenius Kabi Recent Development
Table 120. Hospira(Pfizer) Corporation Information
Table 121. Hospira(Pfizer) Description and Business Overview
Table 122. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Hospira(Pfizer) Product
Table 124. Hospira(Pfizer) Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Mylan Product
Table 129. Mylan Recent Development
Table 130. Taj Pharmaceuticals Corporation Information
Table 131. Taj Pharmaceuticals Description and Business Overview
Table 132. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Taj Pharmaceuticals Product
Table 134. Taj Pharmaceuticals Recent Development
Table 135. Jiangsu Hengrui Medicine Corporation Information
Table 136. Jiangsu Hengrui Medicine Description and Business Overview
Table 137. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Jiangsu Hengrui Medicine Product
Table 139. Jiangsu Hengrui Medicine Recent Development
Table 140. Nanjing Pharmaceutical Factory Corporation Information
Table 141. Nanjing Pharmaceutical Factory Description and Business Overview
Table 142. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Nanjing Pharmaceutical Factory Product
Table 144. Nanjing Pharmaceutical Factory Recent Development
Table 145. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 146. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 147. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Jiangsu Aosaikang Pharmaceutical Product
Table 149. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 150. Qilu Pharmaceutical Corporation Information
Table 151. Qilu Pharmaceutical Description and Business Overview
Table 152. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Qilu Pharmaceutical Product
Table 154. Qilu Pharmaceutical Recent Development
Table 155. Hisun Pharmaceutical Corporation Information
Table 156. Hisun Pharmaceutical Description and Business Overview
Table 157. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Hisun Pharmaceutical Product
Table 159. Hisun Pharmaceutical Recent Development
Table 160. Luoxin Corporation Information
Table 161. Luoxin Description and Business Overview
Table 162. Luoxin Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Luoxin Product
Table 164. Luoxin Recent Development
Table 165. Lingnan Pharmacy Corporation Information
Table 166. Lingnan Pharmacy Description and Business Overview
Table 167. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Lingnan Pharmacy Product
Table 169. Lingnan Pharmacy Recent Development
Table 170. Hansoh Pharma Corporation Information
Table 171. Hansoh Pharma Description and Business Overview
Table 172. Hansoh Pharma Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Hansoh Pharma Product
Table 174. Hansoh Pharma Recent Development
Table 175. Platinum-based Anticancer Drugs Market Trends
Table 176. Platinum-based Anticancer Drugs Market Drivers
Table 177. Platinum-based Anticancer Drugs Market Challenges
Table 178. Platinum-based Anticancer Drugs Market Restraints
Table 179. Platinum-based Anticancer Drugs Customers List
Table 180. Platinum-based Anticancer Drugs Distributors List
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Platinum-based Anticancer Drugs Product Picture
Figure 2. Global Platinum-based Anticancer Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Cisplatin Product Picture
Figure 4. Carboplatin Product Picture
Figure 5. Oxaliplatin Product Picture
Figure 6. Nedaplatin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Platinum-based Anticancer Drugs Sales Market Share by Application in 2020 & 2027
Figure 9. Testicular Cancer

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs